Walleye Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.77M Buy
321,567
+298,662
+1,304% +$4.37M 0.02% 832
2025
Q4
$365K Buy
22,905
+16,512
+258% +$234K ﹤0.01% 3163
2025
Q3
$70.6K Buy
6,393
+1,150
+22% +$12.6K ﹤0.01% 3873
2025
Q2
$44.4K Buy
5,243
+630
+14% +$5.05K ﹤0.01% 4071
2025
Q1
$37.1K Buy
+4,613
New +$37.4K ﹤0.01% 3916
2024
Q2
Sell
-1,279
Closed -$6.41K 5572
2024
Q1
$6.41K Buy
+1,279
New +$8.68K ﹤0.01% 5120
2023
Q1
Sell
-82,245
Closed -$355K 3927
2022
Q4
$355K Sell
82,245
-214,463
-72% -$1.24M 0.01% 1675
2022
Q3
$2.23M Buy
+296,708
New +$2.57M 0.04% 494
2022
Q2
Sell
-34,586
Closed -$428K 2350
2022
Q1
$428K Buy
+34,586
New +$535K 0.01% 1094
2020
Q1
Sell
-68,570
Closed -$1.39M 933
2019
Q4
$1.39M Buy
+68,570
New +$632K 0.09% 308

Other funds holding AUPH